FGF23 and amyotrophic lateral sclerosis: Overall, FGF23 immunoreactivity was observed consistently in ALS denervated muscle, localized mainly to the endomysial connective tissue and muscle membrane, with significantly higher intensity in areas of grouped atrophy.